Topical JAK Inhibitor Development – the Promise & the Challenges

Time: 4:10 pm
day: Day One


  • Exploring how efficacy compares with oral JAKs
  • Recalling what methods are available to assess skin penetration and target occupancy
  • Detailing whether lower systemic exposure leads to a better safety profile
  • Sharing the regulatory challenges